IL9 and lung carcinoma: To explore this concept under in vivo conditions, we next studied the effects of neutralizing anti-IL-9 antibodies in our experimental lung cancer model induced by LL/2 cells in vivo. To this aim, we blocked IL-9 repeatedly during lung tumor development in WT mice via intraperitoneal injection of anti-IL-9 antibodies (Figure 8A).